[-]Narrow by subject
There are no subject folders to display
Did you mean: nasal lamely ?
- IRIS Summary on Acrolein (CASRN 107-02-8)01-28-2010
- "This is a summary of infornation on Acrolein (CASRN 107-02-8) provided by the Integrated Risk Information System (IRIS)"
- Acrolein (CASRN 107-02-8) | IRIS | US EPA01-28-2010
-
- Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... Incidence data were not reported, but histopathological changes in the nasal cavity, lung, larynx, and trachea were graded as slightly, moderately ...
- Acrolein (CASRN 107-02-8) | IRIS | US EPA07-09-2009
-
- Abnormal breathing and nasal/eye discharge were among the clinical findings in high-dose ... Incidence data were not reported, but histopathological changes in the nasal cavity, lung, larynx, and trachea were graded as slightly, moderately ...
![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif)
